Literature DB >> 12843104

Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil.

Libera M Dalla-Costa1, Juliana M Coelho, Helena A P H M Souza, Maria E S Castro, Christiane J N Stier, Karin L Bragagnolo, Alvaro Rea-Neto, Sergio R Penteado-Filho, David M Livermore, Neil Woodford.   

Abstract

Carbapenem-resistant Acinetobacter baumannii isolates were obtained from eight patients in two hospitals in Curitiba, Brazil. The isolates were multiresistant, belonged to a single strain, and produced the OXA-23 carbapenemase. Treatment options were limited, although the isolates were susceptible to polymyxin B in vitro. The strain contributed to the deaths of five patients.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12843104      PMCID： PMC165295          DOI： 10.1128/JCM.41.7.3403-3406.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  16 in total

1.  Sequence analysis of ARI-1, a novel OXA beta-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92.

Authors:  H M Donald; W Scaife; S G Amyes; H K Young
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

2.  Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece.

Authors:  A Tsakris; S Pournaras; N Woodford; M F Palepou; G S Babini; J Douboyas; D M Livermore
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

3.  Endemic carbapenem resistance associated with OXA-40 carbapenemase among Acinetobacter baumannii isolates from a hospital in northern Spain.

Authors:  F Lopez-Otsoa; L Gallego; K J Towner; L Tysall; N Woodford; D M Livermore
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

4.  Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.

Authors:  A S Levin; A A Barone; J Penço; M V Santos; I S Marinho; E A Arruda; E I Manrique; S F Costa
Journal:  Clin Infect Dis       Date:  1999-05       Impact factor: 9.079

Review 5.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

6.  Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii.

Authors:  M Afzal-Shah; N Woodford; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

7.  OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain.

Authors:  G Bou; A Oliver; J Martínez-Beltrán
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

Review 8.  Acquired carbapenem-hydrolyzing beta-lactamases and their genetic support.

Authors:  L Poirel; P Nordmann
Journal:  Curr Pharm Biotechnol       Date:  2002-06       Impact factor: 2.837

9.  In vitro activities of new beta-lactam antibiotics against Acinetobacter spp.

Authors:  I Garcia; V Fainstein; B LeBlanc; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

10.  ARI 1: beta-lactamase-mediated imipenem resistance in Acinetobacter baumannii.

Authors:  R Paton; R S Miles; J Hood; S G Amyes; R S Miles; S G Amyes
Journal:  Int J Antimicrob Agents       Date:  1993-02       Impact factor: 5.283
View more
  58 in total

1.  Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40.

Authors:  Karen Lolans; Thomas W Rice; L Silvia Munoz-Price; John P Quinn
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents.

Authors:  Juliana Coelho; Neil Woodford; Mariya Afzal-Shah; David Livermore
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

3.  Dissemination of Acinetobacter baumannii clones with OXA-23 Carbapenemase in Colombian hospitals.

Authors:  Maria Virginia Villegas; Juan Nicolas Kattan; Adriana Correa; Karen Lolans; Ana Maria Guzman; Neil Woodford; David Livermore; John P Quinn
Journal:  Antimicrob Agents Chemother       Date:  2007-04-02       Impact factor: 5.191

4.  Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-23 in Acinetobacter baumannii.

Authors:  Stéphane Corvec; Laurent Poirel; Thierry Naas; Henri Drugeon; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

5.  OXA-58, a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii.

Authors:  Laurent Poirel; Sophie Marqué; Claire Héritier; Christine Segonds; Gérard Chabanon; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

6.  Clonal spread of imipenem-resistant Acinetobacter baumannii among different cities of China.

Authors:  Hua Zhou; Qing Yang; Yun-Song Yu; Ze-Qing Wei; Lan-Juan Li
Journal:  J Clin Microbiol       Date:  2007-10-17       Impact factor: 5.948

Review 7.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

8.  Molecular characteristics and resistant mechanisms of imipenem-resistant Acinetobacter baumannii isolates in Shenyang, China.

Authors:  Jing Ping Zhang; Wan Zhu; Su Fei Tian; Yun Zhuo Chu; Bai Yi Chen
Journal:  J Microbiol       Date:  2010-11-03       Impact factor: 3.422

9.  Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region.

Authors:  Hsien Chang Chang; Yu Fang Wei; Lenie Dijkshoorn; Mario Vaneechoutte; Chung Tao Tang; Tsung Chain Chang
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

10.  Carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme: dissemination in Southern Brazil.

Authors:  A F Martins; R Kuchenbecker; T Sukiennik; R Boff; K C Reiter; L Lutz; A B M P Machado; A L Barth
Journal:  Infection       Date:  2009-09-18       Impact factor: 3.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.